PATENT CLAIM ANALYSIS

Application Number: 16144916
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "094000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as arthritis.

Claim (Index 13):
The method of  claim 4 , wherein the dosage form contains an amount of the disodium salt form of zoledronic acid that is equivalent to about 40 mg to about 60 mg of the free acid form of zoledronic acid.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16002888', '15934785', '15952017', '15989641', '15432777']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8629675359708278
- 35 USC 102 Novelty (BERT): 0.662780655821533
- Combined Prediction Score: 0.8429488479558983
- Mean Citation Score: 612.5456360000002
- Max Citation Score: 617.901
- Similarity Product: 429.78691162776937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test